Pig-to-Human Organ Transplants Edge Closer to Clinical Reality
After 120 years of failed attempts, genetic engineering is finally making xenotransplantation viable. Here's where the science stands.
20 articles
After 120 years of failed attempts, genetic engineering is finally making xenotransplantation viable. Here's where the science stands.
New review explores how artificial intelligence, pig organs, and regenerative medicine may solve the organ shortage crisis.
Researchers identify how host macrophages destroy foreign cells in embryos — and three strategies to stop it, boosting organ-growing chimeras.
Xenotransplantation, 3D bioprinting, and stem cell therapies are converging to solve the global organ shortage crisis.
A dual human-primate trial finds donor MSC infusions are safe but do not establish chimerism or tolerance, and may trigger rejection-causing antibodies.
Researchers propose targeting lymph node entry mechanisms to improve immune tolerance in cardiac transplant recipients, potentially reducing rejection.
Researchers shift from systemic B-cell targeting to localized immune control, potentially improving transplant success rates.
Researchers propose using partial reprogramming to rejuvenate donor organs outside the body before transplantation.
A novel class of ferroptosis inhibitors protects donor organs from ischemia-reperfusion injury, potentially saving thousands of transplant patients annually.
Scientists combine tissue engineering and transplantation to build a working esophageal graft, marking a step toward lab-grown organ replacements.
Researchers explore targeted immune strategies to improve pancreatic islet transplant success rates for diabetes treatment.
Review explores how transplant medications affect cellular communication particles that trigger immune rejection responses.
Breakthrough crystal technology enables transplanted insulin-producing cells to survive and function for a full year without traditional immunosuppression.
Study reveals regional microbiome mismatches from FMT can lead to persistent off-target effects on metabolism and immunity.
A translational review outlines how stem cell technologies may finally make hepatocyte-based liver therapies clinically viable.
Transplant recipients face dramatically higher cancer rates, especially skin and virus-linked tumors, requiring intensive surveillance.
Scientists discover NKX6.1 gene expression can predict which pancreatic islet transplants will succeed in treating type 1 diabetes.
Breakthrough tissue engineering creates working esophageal segments that support normal feeding and growth in minipigs.
A novel dual CAR T-cell approach eliminated blocking antibodies in highly sensitized patients, enabling kidney transplants previously considered impossible.
Blocking zinc transport in stem cell-derived pancreatic islets improves their survival and function after transplantation for diabetes treatment.